MedPath

A clinical trial to evaluate the efficacy of wound instillation with ropivacine with fentanyl or dexmedetomidine or morphine for post operative analgesia in patients undergoing mastectomy.

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2020/11/028900
Lead Sponsor
PT BD SHARMA PGIMS ROHTAK
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult female patients

Age between 30-70 years

ASA Physical Status Class I & II scheduled for mastectomy with axillary clearance.

Exclusion Criteria

Patients with uncontrolled cardiovascular, pulmonary, hepatic, renal, neurologic, psychiatric diseases or diabetes mellitus; major blood loss during surgery or continued excessive blood collection in to the drains and having allergy to the study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 Pain Score <br/ ><br>2 Duration of analgesia <br/ ><br>3 Need for rescue analgesia <br/ ><br>4 Side effects if anyTimepoint: Intra operative and 24 hour post operative period
Secondary Outcome Measures
NameTimeMethod
Heart rate Blood pressure Spo2 <br/ ><br>Visual Analogue Score at Rest <br/ ><br>Visual Analogue Score on movementTimepoint: Intra operative and 24 hour post operative period
© Copyright 2025. All Rights Reserved by MedPath